MLAB — Mesa Laboratories Share News
0.000.00%
- $749.83m
- $859.03m
- $249.13m
Brief: Mesa Laboratories Q3 EPS USD -0.31
Mesa Laboratories Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Mesa Laboratories Q2 EPS USD 0.63
Mesa Laboratories Inc reports results for the quarter ended in June - Earnings Summary
Brief: Mesa Laboratories Q1 EPS USD 0.62
Brief: Mesa Laboratories Q4 EPS USD -47.2
Mesa Laboratories Inc expected to post a loss of 11 cents a share - Earnings Preview
Mesa Laboratories Inc expected to post a loss of 11 cents a share - Earnings Preview
Brief: Mesa Labs Announces Amendment To Credit Facility, Repurchase Of Senior Convertible Notes
Brief: Mesa Laboratories To Record Non-Cash Impairment Losses Related To Clinical Genomics & Biopharmaceutical Development Units Of $271 Million In Q4 Of 2024
Mesa Laboratories Inc reports results for the quarter ended in December - Earnings Summary
Brief: Mesa Labs Announces Third Quarter Results
Brief: Mesa Laboratories Q3 EPS USD 0.39
Mesa Laboratories Inc expected to post earnings of 19 cents a share - Earnings Preview
Brief: Mesa Laboratories Appoints Mark Capone to its Board of Directors
Brief: Mesa Labs Completes The Acquisition Of Gke Science & Technology Co.
Mesa falls on surprise quarterly loss
Corrected: BRIEF-Mesa Laboratories Q2 Revenue USD 53.16 Million
Mesa Laboratories Inc expected to post earnings of 16 cents a share - Earnings Preview